Print Page | Contact Us | Sign In | Join MAPA
2020 Spring CME Conference
Register Tell a Friend About This EventTell a Friend
2020 Spring CME Conference

Save the date!

 Export to Your Calendar 3/28/2020
When: Saturday, March 28
7:00 AM - 4:30 PM
Where: Lahey Medical Center
41 Mall Road
Burlington, Massachusetts 
United States
Contact: Stephen Gillies
978-674-6212


Online registration is available until: 3/28/2020
« Go to Upcoming Event List  


Conference Overview

Support MAPA by attending this year's Spring Conference at Lahey Medical Center. MAPA has an exciting CME event planned and we want you to experience it! Up to date educational topics on arthritis, heart failure, and the future of healthcare as well as a panel discussion regarding diabetes, as well as legislative updates for Massachusetts PA's. Don't forget about the breakout sessions for buprenorpine waver training. There will be time to network with your peers and industry! Not a PA, no problem! We welcome all professions.

 

Registration Rates


Early Bird
until Feb 28
Regular
Feb 28 - March 27
Onsite
March 28 
 Member $140 $155 $170
 Non-Member $200  $215 $230
 Student Member $30  $30  $30 
 Student Non-Member $40  $40  $40 


Conference Agenda

Click here to view the agenda.

 

Parking 

Parking is located at the Lahey Medical Center parking garage. Rate is $8.00 per car for the day. Parking at own cost.

 

Ultrasound Breakout Sessions 

Member   Non-Member
$40   $50

 

Objectives:

This course reviews the clinical indication for ultrasound use in traumatic injury, the appropriate sonographic views in the FAST protocol, and normal and abnormal sonographic findings. Attendees will have the opportunity to practice the FAST protocol on live models using ultrasound imaging systems.

Course level: 

Advanced (PA-students will be wait-listed and notified of course opening at registration).

Course objectives

Upon completion of this course, attendees should be able to:

• Discuss basic ultrasound image controls and image optimization techniques
• Explain the appropriate transducer selection for FAST exams
• Explain the four major views associated with the FAST exam and the normal anatomy associated with each view
• Discuss the abnormal sonographic findings that can be associated with traumatic injury


MAT Waiver Training

This event is intended to provide eight hours of required training for providers seeking their buprenorphine waivers

Cost: $40

Due to the grants received, there is no registration fee for this training. There is a mandatory $40 fee to cover the cost of your breakfast and lunch.

Description:

This eight-hour course prepares physicians, nurse practitioners and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.

A light breakfast and lunch will be provided. Parking is $8.00 for the day at Lahey Medical Center garage and is at own cost.

Objectives:

At the conclusion of this activity, participants should be able to:

  • Screen and identify patients with OUD and define evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss all FDA approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Recognize the importance of obtaining a waiver to begin treating patients with OUD.

Sponsored by

Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS). 
American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health , the Bureau of Substance Abuse Services and American Academy of Addiction Psychiatry.  American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credential Center (ANCC) to provide continuing education for the healthcare team.

In 2020, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA) and Association for Social Work Boards (ASWB).

 

Interprofessional Continuing Education (IPCE)

Designation Statement: This activity was planned by and for the healthcare team, and learners will receive 8 (eight) Interprofessional Continuing Education credits for learning and change.

Physician Designation Statement: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP's Joint Accreditation provider #4008192. This program is approved for up to 8 Nursing Contact Hours.

 

 

PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.